IHLMA.org

Experimental hearing loss drug Progenitor Cell Activator enters phase 2 of testing

The drug, known as Progenitor Cell Activator or FX-322 is given via injection into the ear drum. Researchers hope it will successfully and safely convert stem cells into stereocilia, the hair cells in the cochlea that are responsible for hearing.

Check out the full report, via Healthy Hearing.

 - 
Arabic
 - 
ar
Danish
 - 
da
English
 - 
en
Finnish
 - 
fi
French
 - 
fr
German
 - 
de
Portuguese
 - 
pt
Spanish
 - 
es
Swedish
 - 
sv